Evidence map›Paper›PMID 41596145›Full record

ReviewAntioxidants (Basel, Switzerland)2026

Polyphenols from Byproducts: Their Applications and Health Effects.

Ranya Demir, Sümeyye Sarıtaş, Mikhael Bechelany, Sercan Karav

Abstract readReview
In one paragraph

Review in Antioxidants (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ranya DemirDepartment of Molecular Biology and Genetics, Çanakkale Onsekiz Mart University, Çanakkale 17000, Türkiye.
Sümeyye SarıtaşDepartment of Molecular Biology and Genetics, Çanakkale Onsekiz Mart University, Çanakkale 17000, Türkiye.
Mikhael BechelanyEuropean Institute for Membranes (IEM), UMR-5635, University of Montpellier, ENSCM, CNRS, Place Eugène Bataillon, CEDEX 5, F-34095 Montpellier, France.ORCID 0000-0002-2913-2846
Sercan KaravDepartment of Molecular Biology and Genetics, Çanakkale Onsekiz Mart University, Çanakkale 17000, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plant byproducts represent a valuable and underutilized source of bioactive compounds. Among these, phenolic compounds have attracted growing interest from the agricultural, cosmetic, and food industries due to their diverse biological activities. These naturally occurring compounds are derived from various plant species, and they exhibit strong antioxidant, antimicrobial, and antiviral properties. Their yield, as well as quality and bioavailability, has improved with more recent advancements within green extraction, as well as purification and characterization techniques. Several phenolic compounds exhibit strong antiviral and antioxidant activities, which are highlighting their value as bioactive compounds. It is essential to evaluate extraction methods for high-yield phenolic compounds from plant byproducts so that they can contribute to the circular bioeconomy, reduction in environmental waste, and development of biomedical and food industrial applications. Their physicochemical characteristics and potential applications may lead to a determination by contributing to promising fields through expanded in vitro, in vivo, and in silico experiments. This review summarizes current research on the extraction, recovery, and applications of phenolic compounds derived from plant byproducts, providing new insights into their sustainable utilization and bioactive potential.

Indexed as

agricultural biomassantimicrobialantioxidantantiviraleco-friendlygreen methodsecondary metabolitessustainability

Identifiers

PMID41596145
PMCPMC12838092

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.